Neglected Disease Research and Development How Much Are We Really Spending 英文参考文献.docVIP

Policy Forum Neglected Disease Research and Development: How Much Are We Really Spending? Mary Moran*, Javier Guzman, Anne-Laure Ropars, Alina McDonald, Nicole Jameson, Brenda Omune, Sam Ryan, Lindsey Wu T he need for new pharmaceutical tools to prevent and treat neglected diseases is widely first G-FINDER report (http://www. /prpppubs). developing-country presentations of Type II diseases, which are “incident in both rich and poor countries, but with a substantial proportion of the cases in the poor countries” and where RD is “not in proportion to global need or addressed to the specific di